NutriBand (NTRB) Interest Expenses (2017 - 2026)
NutriBand (NTRB) posted Interest Expenses of $5.2 million for Q2 2026, up 32699.84% sequentially from -$15951.0 in Q1 2026, and up 21937.63% YoY from N/an in Q2 2025.
NutriBand (NTRB) Interest Expenses (2017 - 2026) Analysis & Trends
NutriBand has reported Interest Expenses for 10 years, with the latest figure at $5.2 million in Q2 2026.
- Quarterly Interest Expenses rose 21937.63% year-over-year to $5.2 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $5.1 million (up 21502.63% YoY) and the FY2026 annual result came in at $9.5 million, up 18.94% from the prior year.
- Interest Expenses improved to $5.2 million in Q2 2026 per NTRB's latest filing, from -$15951.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $8.0 million in Q1 2025 and troughed at -$109906.0 in Q1 2023.
- A 5-year average of $1.5 million and a median of $113109.0 in 2022 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses tumbled 200.86% in 2023, then jumped 34455.05% in 2025.
- Over 5 years, Interest Expenses stood at $109656.0 in 2022, then slumped by 52.03% to $52601.0 in 2023, then jumped by 7770.19% to $4.1 million in 2024, then decreased by 17.2% to $3.4 million in 2025, then jumped by 51.7% to $5.2 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $5.2 million, -$15951.0, and $3.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 | 5,008.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 5.20 Mn |
| Apr 30, 2026 | 5.20 Mn |
| Jan 31, 2026 | -15,951.00 |
| Jan 31, 2026 | -15,951.00 |
| Oct 31, 2025 | 3.43 Mn |
| Oct 31, 2025 | 3.43 Mn |
| Jul 31, 2025 | 4.82 Mn |
| Jul 31, 2025 | 4.82 Mn |
| Apr 30, 2025 | 23,596.00 |
| Apr 30, 2025 | 23,596.00 |
| Jan 31, 2025 | 8.02 Mn |
| Jan 31, 2025 | 8.02 Mn |
| Oct 31, 2024 | 4.14 Mn |
| Oct 31, 2024 | 4.14 Mn |
| Jul 31, 2024 | 298,299.00 |
| Jul 31, 2024 | 298,299.00 |
| Apr 30, 2024 | 120,460.00 |
| Apr 30, 2024 | 120,460.00 |
| Jan 31, 2024 | 23,214.00 |
| Jan 31, 2024 | 23,214.00 |